lenacapavir's 88% response was based on .5 log10 r

lenacapavir's 88% response was based on .5 log10 reduction (about 66% reduction in viral load) unknown what the average starting load was.

leronlimab's 95% @ 525mg - 31 weeks and 92% @ 700mg - 20 weeks was at >= 50 copies/ml , 1.83 log10 decrease 98%.